Følg
Jeffrey Bishop
Tittel
Sitert av
Sitert av
År
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …
JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ...
Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015
10232015
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ...
Clinical pharmacology and therapeutics 102 (1), 37, 2017
6632017
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study
SK Hill, JL Reilly, RSE Keefe, JM Gold, JR Bishop, ES Gershon, ...
American Journal of Psychiatry 170 (11), 1275-1284, 2013
4222013
Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP)
CA Tamminga, EI Ivleva, MS Keshavan, GD Pearlson, BA Clementz, ...
American Journal of psychiatry 170 (11), 1263-1274, 2013
3742013
Effect of second-generation antipsychotics on cognition: current issues and future challenges
SK Hill, JR Bishop, D Palumbo, JA Sweeney
Expert review of neurotherapeutics 10 (1), 43-57, 2010
3132010
Pharmacological treatment effects on eye movement control
JL Reilly, R Lencer, JR Bishop, S Keedy, JA Sweeney
Brain and cognition 68 (3), 415-435, 2008
2702008
Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss …
DA Scott, R Wang, TM Kreman, M Andrews, JM McDonald, JR Bishop, ...
Human Molecular Genetics 9 (11), 1709-1715, 2000
2142000
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy
JT Brown, JR Bishop, K Sangkuhl, EL Nurmi, DJ Mueller, JC Dinh, ...
Clinical Pharmacology & Therapeutics 106 (1), 94-102, 2019
2012019
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …
CA Bousman, JM Stevenson, LB Ramsey, K Sangkuhl, JK Hicks, ...
Clinical Pharmacology & Therapeutics 114 (1), 51-68, 2023
1652023
A review of estrogen receptor α gene (ESR1) polymorphisms, mood, and cognition
EE Sundermann, PM Maki, JR Bishop
Menopause 17 (4), 874-886, 2010
1612010
Review and consensus on pharmacogenomic testing in psychiatry
CA Bousman, SA Bengesser, KJ Aitchison, AT Amare, H Aschauer, ...
Pharmacopsychiatry 54 (01), 5-17, 2021
1582021
Serotonin 2A− 1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects
JR Bishop, J Moline, VL Ellingrod, SK Schultz, AH Clayton
Neuropsychopharmacology 31 (10), 2281-2288, 2006
1362006
Association of choroid plexus enlargement with cognitive, inflammatory, and structural phenotypes across the psychosis spectrum
P Lizano, O Lutz, G Ling, AM Lee, S Eum, JR Bishop, S Kelly, O Pasternak, ...
American Journal of Psychiatry 176 (7), 564-572, 2019
1262019
Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers
J G Fiedorowicz, D Del Miller, J R Bishop, C A Calarge, V L Ellingrod, ...
Current psychiatry reviews 8 (1), 25-36, 2012
1202012
Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia
C Chen, C Zhang, L Cheng, JL Reilly, JR Bishop, JA Sweeney, HY Chen, ...
Bipolar disorders 16 (8), 790-799, 2014
1162014
Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options
K Drozda, DJ Müller, JR Bishop
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (2 …, 2014
1162014
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders
LH Rubin, CS Carter, JR Bishop, H Pournajafi-Nazarloo, LL Drogos, ...
Schizophrenia bulletin 40 (6), 1374-1384, 2014
1092014
Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.
VL Ellingrod, JR Bishop, J Moline, YC Lin, DD Miller
Psychopharmacology bulletin 40 (1), 57-62, 2007
1012007
Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment
JR Bishop, VL Ellingrod, J Moline, D Miller
Schizophrenia research 77 (2-3), 253-260, 2005
992005
Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis
P Lizano, O Lutz, Y Xu, LH Rubin, L Paskowitz, AM Lee, S Eum, SK Keedy, ...
Molecular psychiatry 26 (7), 3430-3443, 2021
982021
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20